Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

3.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.5K
Preventive Healthcare Services01:30

Preventive Healthcare Services

1.2K
Preventive healthcare services keep people healthy via frequent check-ups, screening, and counseling. They primarily aid in disease prevention rather than treating an acute or chronic illness. Preventive treatment also keeps individuals productive and energetic, allowing them to work well into their retirement years. Examples of preventive care services include:
1.2K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

2.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.2K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

1.3K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.3K
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

360
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
360
Levels of Health Promotion and Illness Prevention01:26

Levels of Health Promotion and Illness Prevention

13.7K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
13.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Reply.

Obstetrics and gynecology·2020
Same author

The Cost of a Fall Among Older Adults Requiring Emergency Services.

Journal of the American Geriatrics Society·2020
Same author

Predicting vaginal birth after previous cesarean: Using machine-learning models and a population-based cohort in Sweden.

Acta obstetricia et gynecologica Scandinavica·2020
Same author

Extending the second stage of labor in nulliparous women with epidural analgesia: a cost-effectiveness analysis.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·2020
Same author

In Reply.

Obstetrics and gynecology·2020
Same author

Effect of Prophylactic Negative Pressure Wound Therapy vs Standard Wound Dressing on Surgical-Site Infection in Obese Women After Cesarean Delivery: A Randomized Clinical Trial.

JAMA·2020
Same journal

WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

JAMA·2026
Same journal

FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

JAMA·2026
Same journal

HIV May Hide in More Cells Than Previously Thought-Here's What That Could Mean for a Cure.

JAMA·2026
Same journal

US Dietary Supplement Use Increasing, Especially in Older Adults.

JAMA·2026
Same journal

Heat Stress From Climate Change Surges Globally.

JAMA·2026
Same journal

Strength Training Linked With Lower Cardiovascular Disease Risk in Women.

JAMA·2026
See all related articles

Related Experiment Video

Updated: Oct 25, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.0K

Screening for Gestational Diabetes: US Preventive Services Task Force Recommendation Statement.

, Karina W Davidson1, Michael J Barry2

  • 1Feinstein Institutes for Medical Research at Northwell Health, Manhasset, New York.

JAMA
|August 10, 2021
PubMed
Summary
This summary is machine-generated.

Screening pregnant individuals for gestational diabetes mellitus after 24 weeks of gestation offers moderate benefits for maternal and infant health. Early screening before 24 weeks lacks sufficient evidence to determine its benefits and harms.

More Related Videos

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
06:11

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring

Published on: May 17, 2024

841
Universal Screening for Prevention of Reading, Writing, and Math Disabilities in Spanish
14:43

Universal Screening for Prevention of Reading, Writing, and Math Disabilities in Spanish

Published on: July 18, 2020

8.2K

Related Experiment Videos

Last Updated: Oct 25, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.0K
Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring
06:11

Author Spotlight: Exploring the Long-Term Health Impacts of Intracytoplasmic Sperm Injection on Offspring

Published on: May 17, 2024

841
Universal Screening for Prevention of Reading, Writing, and Math Disabilities in Spanish
14:43

Universal Screening for Prevention of Reading, Writing, and Math Disabilities in Spanish

Published on: July 18, 2020

8.2K

Area of Science:

  • Obstetrics & Gynecology
  • Endocrinology
  • Preventive Medicine

Background:

  • Gestational diabetes mellitus (GDM) affects 5.8%-9.2% of pregnancies in the US, increasing risks for maternal and fetal complications.
  • Complications include preeclampsia, fetal macrosomia, birth injuries, neonatal hypoglycemia, and long-term health issues for both mother and child.
  • The USPSTF (U.S. Preventive Services Task Force) reviewed evidence on GDM screening and treatment.

Purpose of the Study:

  • To evaluate the accuracy, benefits, and harms of screening for GDM.
  • To assess the benefits and harms of GDM treatment for pregnant individuals and newborns.

Main Methods:

  • Systematic review commissioned by the USPSTF.
  • Focused on pregnant individuals without pre-existing type 1 or type 2 diabetes.
  • Evaluated screening accuracy, benefits, and harms of GDM interventions.

Main Results:

  • Moderate certainty of moderate net benefit for screening GDM at or after 24 weeks of gestation.
  • Evidence is insufficient to determine benefits and harms of screening before 24 weeks.
  • Screening aims to improve maternal and fetal outcomes.

Conclusions:

  • USPSTF recommends screening for GDM in asymptomatic pregnant individuals at 24 weeks gestation or later.
  • Current evidence is insufficient to assess screening before 24 weeks gestation.
  • Screening at the recommended time can mitigate risks associated with GDM.